NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE139147 Query DataSets for GSE139147
Status Public on Oct 22, 2019
Title BRIN-BD11 pancreatic beta cell mRNA profile upon treatment with Class1 HDAC inhibitor MS-275
Organism Rattus norvegicus
Experiment type Expression profiling by high throughput sequencing
Summary Methods: We performed mRNA sequence analysis by deep sequencing, in triplicate, using Illumina HiSeq to assess the impact of Class1 HDAC inhibitor MS-275 in regulating gene expression in BRIN-BD11 pancreatic beta cells. The transcriptome libraries were constructed using the NEB adapters and were sequenced on at 150 nucleotide read length using the paired-end chemistry. The raw reads were subjected to Adapter and low quality reads removal by Trimmomatic -0.36v. The sequence reads that passed quality filters was mapped to the Rattus_norvegicus Rnor_6.0 using STAR , counted using feature count module of sub reads package and was normalized in DESeq2-3. Differentially expressed genes were selected based on log2-ratio change with p-value <0.05 (Student‘s t test, unpaired). Hierarchical clustering was performed with the programs Cluster (uncentered correlation; average linkage clustering) and Treeview.
Results: We mapped 136,002,940 (136 million reads) reads per sample to rat genome (Rnor_6.0) and observed 97% alignment to the reference rat genome. We found that 1858 genes were up regulated and 624 genes got down regulated on MS-275 treatment (log fold change ≥±2 p value < 0.05).
Inference: Gene ontology reveals that the upregulated pathways upon MS-275 treatment include endocytosis, cAMP signaling, insulin secretion, Wnt signaling PI3K-Akt signaling and thermogenesis while the downregulated genes include histone modification, chromosome organization and cell cycle regulation. The study represents first detailed mRNA profiling of BRIN-BD11 pancreatic beta cell in context of modulation of expression upon treatment with Class1 HDAC inhibitor MS-275.
 
Overall design Effect of Class1 HDAC inhibitor MS-275 on BRIN-BD11 pancreatic beta cell transcriptome
 
Contributor(s) Mitra P, Bele S, Mutha NV, Katika MR
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Oct 21, 2019
Last update date Oct 24, 2019
Contact name PRASENJIT MITRA
E-mail(s) prasenjit.mitra01604@gmail.com
Phone 04066571526
Organization name Dr.Reddy’s Institute of Life Sciences
Street address University of Hyderabad Campus, Gachibowli
City Hyderabad
State/province Telangana
ZIP/Postal code 500032
Country India
 
Platforms (1)
GPL25947 Illumina NovaSeq 6000 (Rattus norvegicus)
Samples (6)
GSM4131965 WT repeat1
GSM4131966 WT repeat2
GSM4131967 WT repeat3
Relations
BioProject PRJNA578636
SRA SRP226423

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE139147_RAW.tar 550.0 Kb (http)(custom) TAR (of TXT)
GSE139147_WTvsMS-275.TXT.gz 950.2 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap